PPMD Venture Pathways

PPMD Venture Pathways is the venture philanthropy arm of Parent Project Muscular Dystrophy (PPMD), a leading nonprofit dedicated to ending Duchenne muscular dystrophy. The program provides critical early-stage funding and strategic support to biotechnology companies developing innovative treatments for Duchenne and Becker muscular dystrophy. By employing a venture philanthropy model, the organization de-risks promising research to attract follow-on investment from larger venture capital firms and pharmaceutical companies. Their investment portfolio includes a wide range of therapeutic approaches, such as gene therapy, exon skipping, and muscle-growth stimulants. Any financial returns generated from these investments are reinvested into the program to fund future research initiatives. Through Venture Pathways, PPMD plays a pivotal role in bridging the gap between laboratory discovery and clinical application for the Duchenne community.